FDA inspection
Fresenius Kabi USA LLC: FDA inspection ending Jun 30, 2022
FDA inspection 1174894 · Official Action Indicated (OAI) · Melrose Park, IL
Key facts
| Inspection ID | 1174894 |
|---|---|
| Firm | Fresenius Kabi USA LLC |
| FEI number | 1450022 |
| Address | 2020 N Ruby St |
| City | Melrose Park |
| State | IL |
| ZIP | 60160 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Jun 30, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data